Omega Diagnostics successfully tests HIV detection devices

Writer, Stock Market Wire
Tuesday, January 29, 2019 - 08:29

Omega Diagnostics said it had successfully manufactured three validation batches of a test kit for HIV.

The Visitect CD4 devices were tested in India, Zimbabwe and the UK, the company said.

Results demonstrated that all three batches performed in line with design goal parameters.

'These validation batches prove we can manufacture at scale and are a requirement for obtaining a CE Mark,' Omega Diagnostics said.

'As previously communicated, we continue to make good progress and expect to complete internal verification work and external performance evaluation of venous whole blood samples during February.'

At 8:29am: (LON:ODX) Omega Diagnostics Group PLC share price was +0.5p at 13.75p

Related content

Omega Diagnostics forecasts annual loss as sales slide

Omega Diagnostics said it expected to post a full-year loss amid a fall in sales.

Adjusted pre-tax losses for the year through March would amount...

Wed, 17/04/2019 - 07:53

Omega Diagnostics gets CE mark for HIV testing kit

Omega Diagnostics said it had CE-marked its disease test for monitoring people living with HIV.

The Visitect CD4 advanced disease test utilised a cut-off of...

Mon, 18/03/2019 - 09:34

Omega Diagnostics receives purchase orders for HIV testing kit

Omega Diagnostics said it had received its first purchase orders for an HIV desting kit.

Purchase orders for Visitect CD4 350 cut-off test came from...

Wed, 06/03/2019 - 08:24

Omega Diagnostics profit propped up by asset sale as sales slip

Medical diagnostics kit supplier Omega Diagnostics reported a rise in first-half profit after proceeds from the sale of its legacy infectious diseases business offset falling...

Mon, 03/12/2018 - 08:34

Omega Diagnostics revenue falls 27% after loss-making units jettisoned

Omega Diagnostics said its revenue fell 27% in the first half after it discontinued two loss-making businesses.

Revenue declined to £5.2m. On a like-for-like basis,...

Wed, 10/10/2018 - 14:37